Literature DB >> 31376136

c-Jun promotes the survival of H9c2 cells under hypoxia via PTEN/Akt signaling pathway.

Fan Wu1,2, Feng Gao1, Siyi He1, Yunhan Jiang2, Guiping Luo2, Yingbin Xiao3.   

Abstract

Ischemia and hypoxia are common pathophysiological characteristics in cardiovascular diseases. c-Jun expression could be induced by extra- or intracellular stimuli and plays a pivotal role in regulating cell survival in response to the stress. However, previous studies of c-Jun in cell proliferation and apoptosis showed conflicting results. In the present study, we demonstrated that the expression of c-Jun was induced by hypoxia in H9c2 cells. Loss of function of c-Jun was investigated by CCK-8, LDH, and TUNEL assays in low oxygen (1% O2) conditions. We revealed that c-Jun could promote cell survival and inhibit cell apoptosis under hypoxia. Knockdown of c-Jun also promoted the expression of apoptosis-related proteins under hypoxia, such as cleaved caspase-3, cleaved caspase-9, Bax, and Bim. Furthermore, we demonstrated that the knockdown of c-Jun inhibited the PTEN/Akt signaling pathway under hypoxia. Our findings suggested that c-Jun protected H9c2 cells from apoptosis and promoted the survival of H9c2 cells under hypoxia via PTEN/Akt signaling pathway.

Entities:  

Keywords:  Apoptosis; Cardiomyocytes; H9c2 cells; Hypoxia; c-Jun

Mesh:

Substances:

Year:  2019        PMID: 31376136     DOI: 10.1007/s13105-019-00695-3

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  29 in total

1.  Protective role of downregulated MLK3 in myocardial adaptation to chronic hypoxia.

Authors:  Siyi He; Shunbi Liu; Xiaochen Wu; Mei Xin; Sheng Ding; Dong Xin; Hui Ouyang; Jinbao Zhang
Journal:  J Physiol Biochem       Date:  2017-05-30       Impact factor: 4.158

Review 2.  The response of the heart and pulmonary arteries to hypoxia, pressure, and volume. A short review.

Authors:  R J Julian
Journal:  Poult Sci       Date:  2007-05       Impact factor: 3.352

Review 3.  JNK-induced apoptosis, compensatory growth, and cancer stem cells.

Authors:  Fei Chen
Journal:  Cancer Res       Date:  2012-01-15       Impact factor: 12.701

4.  miR-138 protects cardiomyocytes from hypoxia-induced apoptosis via MLK3/JNK/c-jun pathway.

Authors:  Siyi He; Peng Liu; Zhao Jian; Jingwei Li; Yun Zhu; Zezhou Feng; Yingbin Xiao
Journal:  Biochem Biophys Res Commun       Date:  2013-11-06       Impact factor: 3.575

Review 5.  Hypoxia-sensitive pathways in intestinal inflammation.

Authors:  Eric Brown; Cormac T Taylor
Journal:  J Physiol       Date:  2017-11-28       Impact factor: 5.182

6.  Hypoxia and myocardial remodeling in human cardiac allografts: a time-course study.

Authors:  Felix Gramley; Johann Lorenzen; Francesco Pezzella; Klaus Kettering; Ewald Himmrich; Cedric Plumhans; Eva Koellensperger; Thomas Munzel
Journal:  J Heart Lung Transplant       Date:  2009-09-26       Impact factor: 10.247

7.  c-Jun protects hypoxia-inducible factor-1alpha from degradation via its oxygen-dependent degradation domain in a nontranscriptional manner.

Authors:  Bing Yu; Ze-Hong Miao; Yi Jiang; Mei-Hong Li; Na Yang; Ting Li; Jian Ding
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

8.  Role of TGF-β-induced Claudin-4 expression through c-Jun signaling in non-small cell lung cancer.

Authors:  Girish Rachakonda; Trung Vu; Lin Jin; Debangshu Samanta; Pran K Datta
Journal:  Cell Signal       Date:  2016-07-15       Impact factor: 4.315

9.  LncRNA TUG1 serves an important role in hypoxia-induced myocardial cell injury by regulating the miR‑145‑5p‑Binp3 axis.

Authors:  Zhongwei Wu; Shengji Zhao; Chunfu Li; Chaoquan Liu
Journal:  Mol Med Rep       Date:  2017-11-20       Impact factor: 2.952

10.  WDR62 mediates TNFα-dependent JNK activation via TRAF2-MLK3 axis.

Authors:  Elad Prinz; Sharon Aviram; Ami Aronheim
Journal:  Mol Biol Cell       Date:  2018-08-09       Impact factor: 4.138

View more
  1 in total

1.  Network Pharmacology Analysis and Experimental Verification Strategies Reveal the Action Mechanism of Danshen Decoction in Treating Ischemic Cardiomyopathy.

Authors:  Mengnan Liu; Gang Yuan; Gang Luo; Xin Guo; Mingtai Chen; Huayi Yang; Fan He; Tingfu Yang; Xinyue Zhang; Qibiao Wu; Hua Zhou; Sijin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-02       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.